Skip to content
Luna Metabolic
Menu

Advertising disclosure We may earn a commission if you start care through some of these links, at no extra cost to you. How we're funded. Order reflects our editorial rubric and our commercial relationships; scores are ours alone.

Head-to-head for women

Breeze Meds vs REMEVi

Breeze Meds and REMEVi both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.

Breeze Meds

Ranked #42 for women · Grade C

Best for: Women who want a simple all-50-states option and are willing to ask for the details the site does not publish.

Visit Breeze Meds
vs

REMEVi

Higher score

Ranked #32 for women · Grade B

Best for: Women who prioritize LegitScript accreditation and nationwide access, and don't mind mid-to-higher pricing.

Visit REMEVi

The verdict for women

Higher Luna Fit Score: REMEVi

REMEVi edges out Breeze Meds on the Luna Fit Score, 85 to 77 (B vs C). Women who prioritize LegitScript accreditation and nationwide access, and don't mind mid-to-higher pricing. The reasoning behind that number is in the REMEVi scorecard.

Breeze Meds is still a genuine option — a straightforward nationwide compounded program with NAD+ alongside the GLP-1 line — but it publishes one headline price and very little else. Weigh the six women's-health factors below against your own priorities; our full Breeze Meds review goes through each of them, and if neither of these two is the one, the Breeze Meds alternatives, scored on the same six factors widens the field.

Side-by-side on the six factors

Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.

Breeze Meds REMEVi
PCOS & hormonal suitability7483
Breeze
REMEVi
Clinical oversight & labs7285
Breeze
REMEVi
Price transparency7682
Breeze
REMEVi
Nationwide access9595
Breeze
REMEVi
Ongoing support7483
Breeze
REMEVi
Cancellation fairness7082
Breeze
REMEVi

Price, access & features

DetailBreeze MedsREMEVi
Luna Fit Score77/100 · C85/100 · B
Overall rank#42#32
SemaglutideFrom $199/mo$199/mo
TirzepatideFrom $299/mo first month, $399/mo thereafter$269/mo
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only

Breeze Meds

Ranked #42 · Grade C

What we like

  • Available in all 50 states, per their own FAQ
  • One inclusive price covering the consultation, prescription review and delivery
  • NAD+ injections available alongside the GLP-1 line for anyone treating metabolic health as one picture

The caveats

  • Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
  • Publishes a single "from $199" figure that names no molecule; the tirzepatide price ($299 first month, $399 after) only appears inside the intake funnel
  • Every quoted figure is for the lowest dose — the funnel says higher doses may cost more, so these are floors, not the price of a titrated dose

REMEVi

Ranked #32 · Grade B

What we like

  • LegitScript-accredited and available in all 50 states
  • Both molecules disclosed, tirzepatide for insulin-resistant PCOS
  • Clear, predictable pricing

The caveats

  • Higher-end pricing — $199 semaglutide, $269 tirzepatide
  • No oral or brand-name option; general program without hormone specialization

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

More head-to-heads

Neither Breeze Meds nor REMEVi is only worth comparing with the other. Breeze Meds is also written up against CoreAge Rx, 16 points apart on the Luna Fit Score — see how Breeze Meds and CoreAge Rx compare on the Luna Fit Score. REMEVi is also written up against CoreAge Rx, 8 points apart — see the REMEVi–CoreAge Rx head-to-head.

Or browse the full comparison hub.